310,236 Shares in Astera Labs, Inc. $ALAB Bought by Clear Street Group Inc.

Clear Street Group Inc. acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the third quarter, Holdings Channel.com reports. The firm acquired 310,236 shares of the company’s stock, valued at approximately $60,744,000. Astera Labs comprises 0.2% of Clear Street Group Inc.’s investment portfolio, making the stock its 26th largest position.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in ALAB. Vanguard Group Inc. grew its position in shares of Astera Labs by 29.6% in the second quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company’s stock valued at $1,089,491,000 after purchasing an additional 2,751,747 shares during the period. Amundi raised its position in shares of Astera Labs by 1,298.6% during the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after purchasing an additional 1,319,643 shares during the last quarter. Rafferty Asset Management LLC acquired a new position in shares of Astera Labs during the 3rd quarter worth about $209,599,000. BNP Paribas Financial Markets lifted its stake in Astera Labs by 577.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock valued at $220,733,000 after buying an additional 960,899 shares in the last quarter. Finally, 1832 Asset Management L.P. boosted its holdings in Astera Labs by 151.4% in the 2nd quarter. 1832 Asset Management L.P. now owns 1,543,500 shares of the company’s stock worth $139,563,000 after buying an additional 929,600 shares during the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Price Performance

Shares of Astera Labs stock opened at $120.31 on Friday. The stock’s 50 day simple moving average is $147.89 and its 200-day simple moving average is $168.11. The stock has a market cap of $20.48 billion, a P/E ratio of 98.61, a P/E/G ratio of 2.37 and a beta of 1.74. Astera Labs, Inc. has a 1-year low of $47.13 and a 1-year high of $262.90.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, beating the consensus estimate of $0.51 by $0.07. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The firm had revenue of $270.58 million during the quarter, compared to analysts’ expectations of $249.46 million. During the same quarter last year, the firm earned $0.37 earnings per share. The business’s revenue for the quarter was up 91.8% on a year-over-year basis. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, research analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CEO Jitendra Mohan sold 94,971 shares of the business’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the transaction, the chief executive officer owned 1,452,739 shares of the company’s stock, valued at approximately $179,863,615.59. The trade was a 6.14% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, General Counsel Philip Mazzara sold 10,000 shares of the company’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $117.47, for a total transaction of $1,174,700.00. Following the completion of the sale, the general counsel directly owned 128,084 shares of the company’s stock, valued at $15,046,027.48. This represents a 7.24% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 224,292 shares of company stock worth $27,676,069 over the last quarter. Corporate insiders own 12.50% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the company. Barclays set a $165.00 price objective on Astera Labs in a research note on Thursday, January 15th. Weiss Ratings lowered Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday, February 23rd. BNP Paribas Exane assumed coverage on Astera Labs in a research report on Thursday, November 20th. They set an “outperform” rating for the company. Loop Capital started coverage on Astera Labs in a research note on Thursday, March 5th. They issued a “buy” rating and a $250.00 price objective for the company. Finally, Morgan Stanley restated an “overweight” rating and issued a $210.00 price objective on shares of Astera Labs in a report on Wednesday, December 3rd. Fifteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $202.22.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.